Nemaria, Kingston Lyster P.

HRN: 21-81-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2025
CEFTRIAXONE 1G (VIAL)
07/11/2025
07/18/2025
IV DRIP
1.2g
Q24
Dengue Fever With Warning Signs;URTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: